Heat therapy with immunotherapy for advanced GI cancer with liver spread
Part of Cancer, Digestive system, Injuries & trauma clinical trials.
This study tests if adding heat therapy (hyperthermia) to immunotherapy can help people with advanced stomach or colorectal cancer that has spread to the liver. It's for patients who have already tried other treatments and are looking for new options.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You have advanced stomach or colorectal cancer that has spread to the liver.
- You have already received at least one round of treatment (for stomach cancer) or two rounds (for colorectal cancer).
- You are able to do light daily activities and are expected to live at least 6 more months.
- You have not had any other cancer in the past.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether combining heat-based treatment of a tumor with immunotherapy drugs can help people with advanced liver cancer that cannot be surgically removed. The goal is to shrink tumors and improve survival by using the body's immune system alongside localized heat treatment.
This trial tests a new treatment that uses heat to target liver tumors and boost the immune system. It is for women with breast cancer that has spread to the liver who cannot have or do not want surgery.
This trial tests if adding heat therapy (hyperthermia) to standard chemotherapy and radiation helps treat rectal cancer that has high-risk features. Heat therapy is thought to make cancer cells more sensitive to treatment.
This trial tests a heat-based treatment for liver cancer tumors that uses multiple methods to destroy cancer cells. It may help people with liver tumors that haven't spread and who are healthy enough for treatment.
This trial tests combining standard chemotherapy and immunotherapy (tirelizumab) with heated chemotherapy given directly into the belly. It aims to treat stomach cancer that has spread to the abdominal lining, and may help shrink or control the cancer.
This trial tests whether adding modulated electro-hyperthermia (a gentle heat treatment) to standard therapy (radiation and chemotherapy) before surgery helps control locally advanced rectal cancer. It is for people whose cancer has not spread to other parts of the body.
Hear when a new Gastrointestinal Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.